Results 171 to 180 of about 2,621,983 (338)

Time-sensitive injuries for the sports medicine surgeon - "Sports Medicine Trauma", Part 1: Upper Extremity. [PDF]

Orthop Rev (Pavia)
Rosenthal RM, Featherall J, Putko RM, McGlone PJ, Feeley SM, Panarello NM, Lilley BM, Rabin S, Lewis DC, Parkes CW, Sanderson RL, Waltz RA, Ernat JJ.   +12 more
europepmc   +1 more source

Translational studies of exosomes in sports medicine - a mini-review. [PDF]

Front Immunol, 2023
Huang H, Chen P, Feng X, Qian Y, Peng Z, Zhang T, Wang Q.   +6 more
europepmc   +1 more source

What is a sports medicine specialist? A pilot study [PDF]

, 2000
Barry H. Thompson, Orla McNally, Sandra O Neill, Domhnall MacAuley   +3 more
openalex   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

#Sportskongres2025: back to the future for the Scandinavian Sports Medicine Congress! [PDF]

BMJ Open Sport Exerc Med
Thorborg K, Jacobsen JS, Krohn LM, Damsbo L, Kaldau NC, Bayer ML.   +5 more
europepmc   +1 more source

Exercise in Older Adults. Perspectives in Exercise Science and Sports Medicine, Volume 8

, 1996
Robert G. McCulloch
openalex   +1 more source

The role of a masters degree as part of higher training in sports and exercise medicine or why do a masters? [PDF]

, 2000
M. O’Brien, Nick Mahony
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Is There a Role of Photoacoustic Imaging in Sports Medicine: Evidence Today. [PDF]

Orthop Surg
Ma C, Chadha AN, Wu C, Giannoudis PV, Guo JJ.   +4 more
europepmc   +1 more source

SensRORing cholesterol to drive protumoral myelopoiesis

Molecular Oncology, EarlyView.
Bleve et al. uncover a cholesterol‐driven immune evasion pathway, where RORγ‐dependent myelopoiesis shapes tumor immunosuppression. Targeting RORγ and PCSK9 emerges as a strategy to boost cancer immunotherapy. Protumoral myelopoiesis is a determinant of immunoevasion and tumor spread in many malignancies.
Sara Gennari, Luigi Nezi, Teresa Manzo
wiley   +1 more source